No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Low-dose capecitabine after standard adjuvant therapy improves disease-free survival in patients with early triple-negative breast cancer

byTeddy Guo

January 7, 2021

in StudyGraphics

Reading Time: 1 min read

Click to read the study in JAMA.

RELATED REPORTS

Susie Wiles’ breast cancer diagnosis drives national screening surge

The Scan by 2 Minute Medicine®: Susie Wiles breast cancer diagnosis drives national screening surge, Jensen Huang’s GTC keynote turns healthcare AI into a pop-culture phenomenon, landmark ACSM guidelines simplify resistance training for longevity, and consumer alert issued for high-pressure cosmetic surgery chains

Delaying pegfilgrastim administration reduces bone pain in breast cancer patients

#VisualAbstract Progression-Free Survival (PFS) was significantly longer with intensive chemotherapy in patients with advanced stage double or triple hit lymphoma (DHL, THL)

RelatedReports

High frequency of germline mutations observed in triple negative breast cancers

The Scan by 2 Minute Medicine®

Susie Wiles’ breast cancer diagnosis drives national screening surge

March 25, 2026

Artificial Intelligence

The Scan by 2 Minute Medicine®: Susie Wiles breast cancer diagnosis drives national screening surge, Jensen Huang’s GTC keynote turns healthcare AI into a pop-culture phenomenon, landmark ACSM guidelines simplify resistance training for longevity, and consumer alert issued for high-pressure cosmetic surgery chains

March 25, 2026

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence

Oncology

Delaying pegfilgrastim administration reduces bone pain in breast cancer patients

March 23, 2026

Quick Take: Diffusion-weighted Imaging of Invasive Breast Cancer: Relationship to Distant Metastasis–free Survival

Oncology

Breast cancer screening with MRI provides modest benefit for high-risk women

March 2, 2026

Glioblastoma phenotypes identified on MRI predict molecular behavior

Carboplatin as a potential adjunct therapy for recurrent high-grade glioma treatment

#VisualAbstract Fondazione Italiana Linfomi (FIL) Phase 3 trial: Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation (HSCT) in mantle cell lymphoma improves progression-free survival (PFS)

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

2 Minute Medicine Rewind January 11, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result